Should You Hold Collplant Biotechnologies Ltd - ADR (CLGN) in Biotechnology Industry?

The 61 rating InvestorsObserver gives to Collplant Biotechnologies Ltd - ADR (CLGN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 79 percent of stocks in the Biotechnology industry, CLGN’s 61 overall rating means the stock scores better than 61 percent of all stocks.

CLGN has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on CLGN!

See Full CLGN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 61 means the stock is more attractive than 61 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Collplant Biotechnologies Ltd - ADR Stock Today?

Collplant Biotechnologies Ltd - ADR (CLGN) stock is trading at $7.01 as of 1:38 PM on Friday, Aug 25, a gain of $0.32, or 4.78% from the previous closing price of $6.69. The stock has traded between $6.51 and $7.10 so far today. Volume today is less active than usual. So far 13,253 shares have traded compared to average volume of 19,113 shares. Click Here to get the full Stock Report for Collplant Biotechnologies Ltd - ADR stock.